Next Stage for Genomics
G
ENOMICS may have come close to becoming a household word this year, thanks to the hype that surrounded the contest to produce the first map of the human genome. But the real race - to discover new medicines using this information - has only just begun.
US-based Human Genome Sciences has been at the forefront of this race. Founded in 1992 by former Harvard Medical School professor William Haseltine, today its chairman and chief executive, HGS could bring its first drug to market in the next three to four years.
In Paris last week for the annual healthcare conference run by bank SG Cowen, Haseltine said the key question facing the industry today was how to …
The rest of this article is only available to active members of Questia
Sign up now for a free, 1-day trial and receive full access to:
- Questia's entire collection
- Automatic bibliography creation
- More helpful research tools like notes, citations, and highlights
- Ad-free environment
Already a member? Log in now.
Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information:
Article title: Next Stage for Genomics.
Contributors: Not available.
Newspaper title: Sunday Business (London, England).
Publication date: December 3, 2000.
Page number: Not available.
© Not available.
COPYRIGHT 2000 Gale Group.
This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.
One moment ...
- Georgia
- Arial
- Times New Roman
- Verdana
- Courier/monospaced
Reset